...
首页> 外文期刊>American Journal of Physiology >Regulation of transcervical permeability by two distinct P2 purinergic receptor mechanisms.
【24h】

Regulation of transcervical permeability by two distinct P2 purinergic receptor mechanisms.

机译:通过两个不同的P2嘌呤能受体机制调节子宫颈通透性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Micromolar concentrations of ATP stimulate biphasic change in transepithelial conductance across CaSki cultures, an acute increase (phase I response) followed by a slower decrease (phase II response). Phase I and phase II responses involve two distinct calcium-dependent pathways, calcium mobilization and calcium influx. To test the hypothesis that phase I and phase II responses are mediated by distinct P2 purinergic receptors, changes in permeability were uncoupled by blocking calcium mobilization with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) or by lowering extracellular calcium, respectively. Under these conditions ATP EC(50) was 25 microM for phase I response and 2 microM for phase II response. The respective agonist profiles were ATP > UTP > adenosine 5'-O-(3-thiotriphosphate) (ATP-gamma S) = N(6)-([6-aminohexyl]carbamoylmethyl)adenosine 5'-triphosphate (A8889) > GTP and UTP > ATP > GTP = A8889 > ATP-gamma S. Suramin blocked phase I response and ATP-induced calcium mobilization, whereas pyridoxal phosphate-6-azophenyl-2',4-disulfonic acid (PPADS) blocked phase II response and ATP-augmented calcium influx. ATP time course and pharmacological profiles for phase II response and augmented calcium influx were similar, with a time constant of 2 min and a saturable concentration-dependent effect (EC(50) of 2-3 microM). RT-PCR experiments revealed expression of mRNA for both the P2Y(2) and P2X(4) receptors. These results suggest that the ATP-induced phase I and phase II responses are mediated by distinct P2 purinergic receptor mechanisms.
机译:ATP的微摩尔浓度会刺激整个CaSki培养物中跨上皮电导的双相变化,即急剧增加(I期反应),然后缓慢降低(II期反应)。 I期和II期反应涉及两种不同的钙依赖性途径,钙动员和钙内流。为了测试I和II期反应是由不同的P2嘌呤能受体介导的假设,通透性的变化通过用1,2-双(2-氨基苯氧基)乙烷-N,N,N',N'阻止钙动员来消除-四乙酸(BAPTA)或通过降低细胞外钙。在这些条件下,ATP EC(50)的I期响应为25 microM,II期响应为2 microM。各自的激动剂谱为ATP> UTP>腺苷5'-O-(3-硫代三磷酸)(ATP-γS)= N(6)-([[6-氨基己基]氨基甲酰基甲基)腺苷5'-三磷酸(A8889)> GTP和UTP> ATP> GTP = A8889>ATP-γS.Suramin阻断I期反应和ATP诱导的钙动员,而吡ido醛磷酸盐-6-偶氮苯基2',4-二磺酸(PPADS)阻断II期反应和ATP。增强的钙内流。 II期反应和钙离子流入增加的ATP时间过程和药理学特征相似,时间常数为2分钟,饱和浓度依赖性效应(EC(50)为2-3 microM)。 RT-PCR实验揭示了P2Y(2)和P2X(4)受体的mRNA表达。这些结果表明,ATP诱导的I期和II期反应是由不同的P2嘌呤能受体机制介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号